Targeted Medical Pharma
- Pharmaceutical Preparations
- Los Angeles, California
Compensation history
Top executives at Targeted Medical Pharma received an average of $443K per person in annual compensation between 2012 and 2013.
Average pay of disclosed executives at Targeted Medical Pharma
By year
- 2013
DS$922KDavid S. SilverPresident and Chief Operating OfficerWS$608KWilliam E. ShellChief Executive Officer and Chief Scientific OfficerKG$476KKim GiffoniExecutive Vice President of Foreign Sales and Investor RelationsAB$337KAmir BlachmanVP of Strategy and Operations and Chief Compliance and Ethics OfficerDG$254KDouglas P. GintzChief Technology and Information OfficerWH$142KWilliam B. HorneChief Financial Officer- 2012
DS$811KDavid S. SilverPresident and Chief Operating OfficerWS$509KWilliam E. ShellChief Executive Officer and Chief Scientific OfficerKG$469KKim GiffoniExecutive Vice President of Foreign Sales and Investor RelationsAB$193KAmir BlachmanVP of Strategy and Operations and Chief Compliance and Ethics OfficerDG$163KDouglas P. GintzChief Technology and Information Officer
Executives
We found six executives who work or worked at Targeted Medical Pharma.
William Shell
Targeted Medical Pharma
Chief Executive Officer
David Silver
Targeted Medical Pharma
Chief Operating Officer
Kim Giffoni
Targeted Medical Pharma
Executive Vice President of Foreign Sales and Investor Relations
Amir Blachman
Targeted Medical Pharma
VP of Strategy and Operations and Chief Compliance and Ethics Officer
William Horne
Targeted Medical Pharma
Chief Financial Officer
Douglas Gintz
Targeted Medical Pharma
Chief Technology and Information Officer
About Targeted Medical Pharma
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address2980 Beverly Glen Circle, Suite 301, Los Angeles, California 90077
- Phone310-474-9809
- Fiscal year endDecember 9
- Former names
- AFH Acquisition III, Inc.Until January 30, 2011
Source: SEC filing on April 30, 2014.